Quantitative urinary organic acid testing measures levels of small organic acids excreted in urine to evaluate cellular metabolism. It helps detect inherited metabolic disorders, mitochondrial dysfunction, vitamin or cofactor deficiencies, and markers of gut dysbiosis or infection. The noninvasive test (single or 24‑hour urine) provides metabolic fingerprints that clinicians use alongside clinical assessment and other tests to diagnose conditions and monitor therapy.

A urine uric acid test measures how much uric acid you excrete in urine. It helps evaluate causes of high blood uric acid, diagnose or monitor gout and uric acid kidney stones, assess kidney function and uric acid metabolism, and monitor effectiveness of treatments that lower uric acid. Abnormal results may prompt further blood tests or imaging for stones or renal problems.

Costs vary widely. In the United States, a comprehensive urine organic acids panel typically costs about $200–$400 without insurance. Private testing in the UK often runs about £100–£300. In India, prices commonly range roughly ₹2,500–₹7,500. Final cost depends on the lab, the specific panel ordered, sample handling, and whether insurance or a physician referral covers part of the fee.

An organic acid is a carbon-based compound that contains one or more carboxyl groups (–COOH) and can donate a proton (H+) in solution. They are typically weak acids found in foods and metabolic pathways. A common example is acetic acid (CH3COOH), the main acid in vinegar; others include citric and lactic acids.

Some acidity in urine is normal—urine pH usually ranges about 4.5–8, often slightly acidic. Diet, medications, hydration and infections affect pH. Persistently very acidic urine can raise the risk of uric‑acid kidney stones or signal conditions like uncontrolled diabetes or prolonged diarrhea. If you have symptoms, repeated abnormal pH tests, or concerns, see your healthcare provider for evaluation and treatment.

Abnormal organic acid levels in urine indicate disruptions in metabolic pathways. Elevated or low markers can point to inborn metabolic disorders, mitochondrial or Krebs‑cycle dysfunction, impaired amino‑acid or fatty‑acid metabolism, vitamin/cofactor deficiencies, oxidative stress, or gut microbial imbalance and toxin exposure. Results need clinical correlation and follow‑up testing to identify causes and guide targeted treatment such as nutrient repletion, infection control, or specialist referral.